NM_020919.4:c.1114-27A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020919.4(ALS2):​c.1114-27A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.161 in 1,504,302 control chromosomes in the GnomAD database, including 23,268 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2498 hom., cov: 32)
Exomes 𝑓: 0.16 ( 20770 hom. )

Consequence

ALS2
NM_020919.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -1.02

Publications

2 publications found
Variant links:
Genes affected
ALS2 (HGNC:443): (alsin Rho guanine nucleotide exchange factor ALS2) The protein encoded by this gene contains an ATS1/RCC1-like domain, a RhoGEF domain, and a vacuolar protein sorting 9 (VPS9) domain, all of which are guanine-nucleotide exchange factors that activate members of the Ras superfamily of GTPases. The protein functions as a guanine nucleotide exchange factor for the small GTPase RAB5. The protein localizes with RAB5 on early endosomal compartments, and functions as a modulator for endosomal dynamics. Mutations in this gene result in several forms of juvenile lateral sclerosis and infantile-onset ascending spastic paralysis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2008]
ALS2 Gene-Disease associations (from GenCC):
  • ALS2-related motor neuron disease
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • amyotrophic lateral sclerosis type 2, juvenile
    Inheritance: AR Classification: STRONG Submitted by: Genomics England PanelApp
  • infantile-onset ascending hereditary spastic paralysis
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Orphanet
  • juvenile primary lateral sclerosis
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Labcorp Genetics (formerly Invitae), Orphanet
  • juvenile amyotrophic lateral sclerosis
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BP6
Variant 2-201757786-T-C is Benign according to our data. Variant chr2-201757786-T-C is described in ClinVar as [Benign]. Clinvar id is 261365.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.39 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALS2NM_020919.4 linkc.1114-27A>G intron_variant Intron 4 of 33 ENST00000264276.11 NP_065970.2 Q96Q42-1A8K4R4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALS2ENST00000264276.11 linkc.1114-27A>G intron_variant Intron 4 of 33 1 NM_020919.4 ENSP00000264276.6 Q96Q42-1

Frequencies

GnomAD3 genomes
AF:
0.169
AC:
25719
AN:
151986
Hom.:
2498
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.186
Gnomad AMI
AF:
0.0724
Gnomad AMR
AF:
0.121
Gnomad ASJ
AF:
0.172
Gnomad EAS
AF:
0.405
Gnomad SAS
AF:
0.336
Gnomad FIN
AF:
0.223
Gnomad MID
AF:
0.149
Gnomad NFE
AF:
0.133
Gnomad OTH
AF:
0.161
GnomAD2 exomes
AF:
0.218
AC:
43400
AN:
199222
AF XY:
0.223
show subpopulations
Gnomad AFR exome
AF:
0.229
Gnomad AMR exome
AF:
0.142
Gnomad ASJ exome
AF:
0.183
Gnomad EAS exome
AF:
0.450
Gnomad FIN exome
AF:
0.243
Gnomad NFE exome
AF:
0.164
Gnomad OTH exome
AF:
0.195
GnomAD4 exome
AF:
0.160
AC:
216950
AN:
1352198
Hom.:
20770
Cov.:
22
AF XY:
0.165
AC XY:
111931
AN XY:
676454
show subpopulations
African (AFR)
AF:
0.203
AC:
6180
AN:
30400
American (AMR)
AF:
0.142
AC:
5973
AN:
41960
Ashkenazi Jewish (ASJ)
AF:
0.176
AC:
4454
AN:
25312
East Asian (EAS)
AF:
0.418
AC:
15918
AN:
38062
South Asian (SAS)
AF:
0.324
AC:
26769
AN:
82660
European-Finnish (FIN)
AF:
0.211
AC:
8314
AN:
39372
Middle Eastern (MID)
AF:
0.172
AC:
929
AN:
5400
European-Non Finnish (NFE)
AF:
0.134
AC:
138233
AN:
1032316
Other (OTH)
AF:
0.179
AC:
10180
AN:
56716
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.528
Heterozygous variant carriers
0
8995
17989
26984
35978
44973
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5154
10308
15462
20616
25770
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.169
AC:
25737
AN:
152104
Hom.:
2498
Cov.:
32
AF XY:
0.175
AC XY:
13027
AN XY:
74346
show subpopulations
African (AFR)
AF:
0.186
AC:
7713
AN:
41482
American (AMR)
AF:
0.121
AC:
1853
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
0.172
AC:
597
AN:
3468
East Asian (EAS)
AF:
0.405
AC:
2096
AN:
5180
South Asian (SAS)
AF:
0.337
AC:
1623
AN:
4822
European-Finnish (FIN)
AF:
0.223
AC:
2358
AN:
10576
Middle Eastern (MID)
AF:
0.150
AC:
44
AN:
294
European-Non Finnish (NFE)
AF:
0.133
AC:
9048
AN:
67996
Other (OTH)
AF:
0.161
AC:
339
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1082
2163
3245
4326
5408
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
302
604
906
1208
1510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.161
Hom.:
556
Bravo
AF:
0.163
Asia WGS
AF:
0.370
AC:
1284
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jul 06, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.92
CADD
Benign
0.086
DANN
Benign
0.42
PhyloP100
-1.0
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs28729117; hg19: chr2-202622509; COSMIC: COSV51885346; COSMIC: COSV51885346; API